Orthopedic Market Faces Stiffer Test in Third Quarter 2023

As earnings announcements roll in for the third quarter, we'll update this article with public orthopedic companies' reported results.

Before that, let’s quickly review the themes that emerged in 2023. Year-over-year sales are elevated, particularly in joint replacement, but tougher comps await in the back half. Supply chain and staffing...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us